Cargando…
Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis
Malignant tumors have become the main cause of harm to human life and health. Development for new antitumor drugs and the exploration to drug carriers are becoming the concerned focus. In this study, we exploited our experiments to explore the effect of NCTD-NLC on liver cancer cells: the HepG2 cell...
Autores principales: | Yan, Zijun, Yang, Kun, Tang, Xiang, Bi, Yunfeng, Ding, Yuzhen, Deng, Mengyue, Xia, Die, Zhao, Yunqi, Chen, Tong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045966/ https://www.ncbi.nlm.nih.gov/pubmed/35497873 http://dx.doi.org/10.1155/2022/3851604 |
Ejemplares similares
-
Involvement of mitochondrial pathway in NCTD-induced cytotoxicity in human hepG2 cells
por: Chang, Cheng, et al.
Publicado: (2010) -
Effect of compositions in nanostructured lipid carriers (NLC) on skin hydration and occlusion
por: Loo, CH, et al.
Publicado: (2013) -
Repression of YAP by NCTD disrupts NSCLC progression
por: Guo, Jiwei, et al.
Publicado: (2016) -
Cytotoxic Effect of Thymoquinone-Loaded Nanostructured Lipid Carrier (TQ-NLC) on Liver Cancer Cell Integrated with Hepatitis B Genome, Hep3B
por: Haron, Aminah Suhaila, et al.
Publicado: (2018) -
In Vitro Studies on Nasal Formulations of Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN)
por: Costa, Cláudia Pina, et al.
Publicado: (2021)